Indian regulation will have to make a decision to either toe the line on gene editing or turn to options that could address its huge healthcare problems.
Shambhavi Naik
Shambhavi Naik is a Research Analyst at the Technology and Policy Programme, the Takshashila Institution. She has a PhD in Cancer Biology from University of Leicester and has worked as a Post-Doctoral Fellow at the MRC Toxicology Unit, National Centre for Biological Sciences and Institute for Stem Cell Biology and Regenerative Medicine in the past.
Early detection and a robust healthcare infrastructure are necessary preparation for biological warfare. And guess what -- we need those anyway.
India should look at the merger between Monsanto and Bayer as an opportunity, not a problem.
We're not sure about the medium through which Nipah spreads. But there are still some precautions we can take.
Genetically modified mosquitoes are being prepared to tackle regular mosquitoes. But we need to proceed with caution.
India lacks Scientific Temper. It is up to our scientists to change this through dialogue and discussion. If they do not engage with society at large, they do a disservice to science.
Genetics has shown that there was movement between India and Europe centuries ago. But science can spread no light on the direction of this migration, whether the migrants were Aryans, and what their culture was like.